Fosamax: a Treatment for Osteoporosis
Fosamax is prescribed primarly for the treatment of Osteoporosis.
Osteoporosis is a disease of bone in which bone mineral density is reduced,
bone microarchitecture is disrupted, and the amount and variety of
non-collagenous proteins in bone is changed.
Osteoporotic bones are more susceptible to fracture.
Osteoporosis is defined by the World Health Organization (WHO) as either a
bone mineral density 2.5 standard deviations below peak bone mass (20-year-old
person standard) as measured by DEXA or any fragility fracture.
While treatment modalities are becoming available, prevention is still the
most important way to reduce fracture.
Due to its hormonal component, more women, particularly after menopause,
suffer from osteoporosis than men.
Recently a connection was found between Fosamax use and
a serious bone disease known as Osteonecrosis of
the Jaw (ONJ). ONJ is also known as Dead Jaw or
rotting of the jaw.
Click To Talk To Us Online
Osteonecrosis of the Jaw
Fosamax Linked with Osteonecrosis - Get a free Fosamax case Eval here
Did you develop Osteonecrosis of the Jaw while taking Fosamax?
Myofascial Pain Syndrome
Fosamax & Myofascial Pain Syndrome - Learn about the connection
Fosamax - Myofascial Pain Syndrome: malfunctioning of the fascial system
Learn More
Learn more about Fosamax - Are you at risk? Find out here
Learn more about Fosamax - Dangerous health risks linked with Fosamax